Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Lancet

Volumn 352, Issue 9128, 1998, Pages 609-613

  Moher, David ^a,b   Pham, Ba' ^c   Jones, Alison ^c   Cook, Deborah J ^c   Jadad, Alejandro R ^c   Moher, Michael ^c   Tugwell, Peter ^c   Klassen, Terry P ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILDBIRTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; META ANALYSIS; METHODOLOGY; PREGNANCY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0032558314     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)01085-X     Document Type: Article

References (30)

1. 1 Chalmers TC. Problems induced by meta-analyses. Stat Med 1991; 10: 971-80.
2. 2 Felson DT. Bias in meta-analytic research. J Clin Epidemiol 1992; 45: 885-92.
3. 3 Marshall JK, Irvine EJ. Rectal amniosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 1995; 9: 293-300.
4. 4 Pace F, Maconi G, Molteni P, Minguzzi M, Bianchi Porro G. Meta-analysis of the effect of placebo on the outcome of medically treated reflux esophagitis. Scand J Gastroenterol 1995; 30: 101-05.
5. 5 Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540-49.
6. 6 Ramirez-Lassepas M, Cipolle RJ. Medical treatment of transient ischemic attacks: does it influence mortality? Stroke 1988; 19: 397-400.
7. 7 Lensing AW, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis. Arch Intern Med 1995; 155: 601-07.
8. 8 Loosemore TM, Chalmers TC, Dormandy JA. A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. Int Angiol 1994; 13: 133-42.
9. 9 Mari JJ, Streiner DL. An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings. Psychol Med 1994; 24: 565-78.
10. 10 Loonen AJ, Peer PG, Zwanikken GJ. Continuation and maintenance therapy with antidepressive agents: meta-analysis of research. Pharmaceutisch Weekblad 1991; 13: 167-75.
11. 11 Dolan-Mullen P, Ramirez G, Groff JY. A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstet Gynecol 1994; 171: 1328-34.
12. 12 Counsell C, Sandercock P. Anticoagulants in acute stroke. In: Cochrane Library. [CDRom and online]: Cochrane Collaboration, issue 2. Oxford: Update Software, 1995.
13. 13 Hughes E, Collins J, Vanderkeckhove P. Bromocriptine, unexplained infertility. In: Cochrane Library [CDRom and online]: Cochrane Collaboration, issue 2. Oxford: Update Software, 1995.
14. 14 Grant A. Elective versus selective caesarean delivery of the small baby. In: Cochrane Library [CDRom and online]: Cochrane Collaboration, issue 2. Oxford: Update Software, 1995.
15. 15 Jadad AR, Cook DJ, Jones A, Klassen T, Tugwell P, Moher M, Moher D. Methodology and reports of systematic reviews and metaanalyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998; 280: 178-280.
16. 16 Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of randomized clinical trials: is blinding necesssary? Control Clin Trials 1996; 17: 1-12.
17. 17 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
18. 18 Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
19. 19 Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Int J Technol Assess Health Care 1996; 12: 195-208.
20. 20 Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992; 45: 255-65.
21. 21 Berlin JA, on behalf of the University of Pennsylvania Meta-analysis Blinding Study Group. Does blinding of readers affect the results of meta-analyses? Lancet 1997; 350: 185-86.
22. 22 Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995; 16: 62-73.
23. 23 McNutt RA, Evans AT, Fletcher RH, Fletcher SW. The effects of blinding on the quality of peer review. JAMA 1990; 263: 1371-76.
24. 24 The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272: 1926-31.
25. 25 The Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Checklist of information for inclusion in reports of clinical trials. Ann Intern Med 1996; 124: 741-43.
26. 26 Begg CB, Cho MK, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-39.
27. 27 Rennie D. How to report randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 649.
28. 28 McNamee D, Horton R. Lies, damn lies, and reports of RCTs. Lancet 1996; 348: 562.
29. 29 Altman DG. Better reporting of randomized controlled trials: the CONSORT statement. BMJ 1996; 313: 570-71.
30. 30 Freemantle N, Mason JM, Haines A, Eccles MP. CONSORT: an important step toward evidence-based health care. Ann Intern Med 1997; 126: 81-83.